CytoDyn Inc. Inventory Write-down
CytoDyn Inc. (CYDY) reported Inventory Write-down of $20.63 million for the 12-month period ending 2023-05-31, per its 10-K filed 2024-08-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2024-08-15
- CytoDyn Inc. inventory write-down for the quarter ending 2023-05-31 was $0.00, a 100.00% decline year-over-year.
- CytoDyn Inc. inventory write-down for the quarter ending 2023-02-28 was $0.00, a 100.00% decline year-over-year.
- CytoDyn Inc. inventory write-down for the quarter ending 2022-11-30 was $17.93M, a 1025.49% increase year-over-year.
- CytoDyn Inc. inventory write-down for the quarter ending 2022-08-31 was $2.70M, a 53.29% increase year-over-year.
- CytoDyn Inc. inventory write-down for fiscal 2023 was $20.63M, a 71.92% decline from fiscal 2022.
- CytoDyn Inc. inventory write-down for fiscal 2022 was $73.49M, a 1361.91% increase from fiscal 2021.
- CytoDyn Inc. inventory write-down for fiscal 2021 was $5.03M.
- CytoDyn Inc. inventory write-down for fiscal 2020 was $0.00.
| Period end | Inventory Write-down 3 month | Inventory Write-down 3 month as first filed | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|---|
| 2023-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-15 | $0.00 derived: sum of 2 quarters · filed 2024-08-15 | $17.93M derived: sum of 3 quarters · filed 2024-08-15 | $20.63M 10-K · filed 2024-08-15 | |
| 2023-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-15 | $17.93M derived: sum of 2 quarters · filed 2024-04-15 | $20.63M 10-Q · filed 2024-04-15 | $85.21M derived: sum of 4 quarters · filed 2024-04-15 | |
| 2022-11-30 | $17.93M 10-Q · filed 2024-01-16 | $20.63M 10-Q · filed 2024-01-16 | $85.21M derived: sum of 3 quarters · filed 2024-01-16 | $90.77M derived: sum of 4 quarters · filed 2024-01-16 | |
| 2022-08-31 | $2.70M 10-Q · filed 2023-10-23 | $67.28M derived: sum of 2 quarters · filed 2023-10-23 | $72.84M derived: sum of 3 quarters · filed 2023-10-23 | $74.43M derived: sum of 4 quarters · filed 2023-10-23 | |
| 2022-05-31 | $64.57M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-14 | $70.13M derived: sum of 2 quarters · filed 2023-09-14 | $71.73M derived: sum of 3 quarters · filed 2023-09-14 | $73.49M 10-K · filed 2023-09-14 | |
| 2022-02-28 | $5.56M 10-Q · filed 2023-04-10 | $7.15M derived: sum of 2 quarters · filed 2023-04-10 | $8.92M 10-Q · filed 2023-04-10 | $9.11M derived: sum of 4 quarters · filed 2023-04-10 | |
| 2021-11-30 | $1.59M 10-Q · filed 2023-01-09 | $3.36M 10-Q · filed 2023-01-09 | $3.55M derived: sum of 3 quarters · filed 2023-01-09 | $9.65M derived: sum of 4 quarters · filed 2023-01-09 | |
| 2021-08-31 | $1.76M 10-Q/A · filed 2022-10-13 | $1.13M 10-Q · filed 2021-10-12 | $1.96M derived: sum of 2 quarters · filed 2022-10-13 | $8.06M derived: sum of 3 quarters · filed 2022-10-13 | $12.86M derived: sum of 4 quarters · filed 2022-10-13 |
| 2021-05-31 | $192.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-15 | $6.29M derived: sum of 2 quarters · filed 2022-08-15 | $11.09M derived: sum of 3 quarters · filed 2022-08-15 | $5.03M 10-K · filed 2022-08-15 | |
| 2021-02-28 | $6.10M 10-Q · filed 2021-04-14 | $10.90M derived: sum of 2 quarters · filed 2022-01-10 | $4.83M 10-Q · filed 2022-04-11 | ||
| 2020-11-30 | $4.80M 10-Q · filed 2022-01-10 | $4.83M 10-Q · filed 2022-01-10 | |||
| 2020-08-31 | $0.00 10-Q · filed 2021-10-12 | ||||
| 2020-05-31 | $0.00 10-K · filed 2021-07-30 | ||||
| 2019-05-31 | $0.00 10-K · filed 2021-07-30 |